Biohaven Pharmaceutical Holding Co. Ltd.(NYSE : BHVN)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -1.88% | 162.11 | 0.7% | $1086.81m | |
| MRK | Merck & Co., Inc. | -0.79% | 76.62 | 0.7% | $1018.44m | |
| PFE | Pfizer Inc. | -1.77% | 38.78 | 0.9% | $918.56m | |
| LLY | Eli Lilly & Co. | -1.68% | 218.47 | 1.1% | $906.20m | |
| ABBV | AbbVie, Inc. | -1.59% | 113.07 | 1.9% | $727.29m | |
| BMY | Bristol-Myers Squibb Co. | -0.34% | 66.54 | 1.0% | $643.98m | |
| AZN | AstraZeneca Plc | 0.03% | 58.37 | 1.2% | $408.15m | |
| ANVS | Annovis Bio, Inc. | 2.78% | 92.55 | 0.0% | $317.09m | |
| OGN | -4.74% | 29.97 | 0.0% | $312.13m | ||
| NVS | Novartis AG | -1.21% | 93.01 | 0.2% | $178.45m | |
| GSK | GlaxoSmithKline Plc | -1.80% | 39.84 | 0.2% | $160.18m | |
| ORPH | Orphazyme A/S | -49.66% | 7.33 | 0.0% | $152.39m | |
| NOVN | Novan, Inc. | 0.18% | 10.87 | 5.8% | $140.49m | |
| CVAC | CureVac NV | 7.11% | 61.94 | 0.0% | $108.62m | |
| CNST | Constellation Pharmaceuticals, Inc. | -0.18% | 33.76 | 0.0% | $107.09m |
Company Profile
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.